These three are the most commonly reported adverse reactions to Brintellix at greater than 5% and twice placebo

Which gender had the highest rates of sexual dysfunction when on Brintellix when
voluntarily reported :
When Asked ASEX

This is the amount of time needed from discontinuing a patient from an MAOI to Brintellix or the time it takes to reach steady state

These are the 5 categories of questions asked in the ASEX scale

This percentage rate An adverse event was reported at both the 15 and 20 mg dose and the reason for discontinuation

The number of patients who reported sexual dysfunction in the Brintellix group versus the placebo group in the 24 to64 week of the long term study

This is the % of patients who continued to experience Nausea at the conclusion of the pooled 6 to 8 week studies at 10 and 20 mgs.

This percentage of patients reported sexual dysfunction in the Katona study; the same percentage compared to placebo but 6% less than the duloxteine group

This was the maximum single dose and gender tested for Brintellix

In the Alvarez study, how many total patients had reported sexual dysfunction in the Brintellix doses compared to the 225 dose of venlafaxine